CABASER 1 MG TABLETS, CABERGOLINE 1 MG TABLETS patient leaflet, side effects, dosage
Some of these side effects (for example, changes in blood pressure, and certain heart, lung and liver conditions) can only be found when your doctor does tests from time to time to check your progress. Pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists including Cabaser (see section 4.4). The concomitant use of antiparkinson non-dopamine agonists (e.g. selegiline, amantadine, biperiden, trihexyphenidyl) was allowed in clinical studies for patients receiving cabergoline. In studies where the pharmacokinetic interactions of cabergoline with L-dopa or selegiline were evaluated, no interactions were observed. Cabaser Tablet contains Cabaser, a dopamine receptor agonist. Cabaser is a dopaminergic ergoline derivative with potent and long-lasting prolactin lowering activity.
2 Dose and Method of Administration
If you have not had dopamine medications before, the final dose is usually between 2-4mg but if Cabaser is being used with levodopa you may take up to 6mg/day. The drug should not be combined with other ergot derivatives. Dopamine antagonists such as antipsychotics and metoclopramide counteract some effects of cabergoline. The use of antihypertensive drugs should be intensively monitored because excessive hypotension may result from the combination.
- 👉 If prolactin levels are higher than normal, it often means there is a type of tumor of the pituitary gland, known as a prolactinoma.
- A repeat-dose study in 12 healthy volunteers suggests that steady-statelevels following a once-weekly dosing schedule are expected to be twofold tothreefold higher than after a single dose.
- All tablets come in child-proof amber glass bottles containing 30 tablets.
Consumer medicine information (CMI) leaflet
It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at /yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Cabergoline should be discontinued if an echocardiogram reveals new or worsened valvular regurgitation, valvular restriction, valve leaflet thickening or fibrotic valvular disease (see section 4.3). The effects of alcohol on overall tolerability of cabergoline are currently unknown. • Evidence of cardiac valvulopathy as determined by pre-treatment echocardiography (see section 4.4). • Hypersensitivity to cabergoline, or any of the excipients listed in section 6.1, or any ergot alkaloid.
Following diagnosis of pleural effusion or pulmonaryfibrosis, the discontinuance of DOSTINEX was reported to result in improvementof signs and symptoms. The impact is immediate (within 3 hours after ingestion) and lasts for a long time. Cabergoline works by preventing the pituitary gland from producing and releasing prolactin hormone. Also tell your doctor if you have persistent cough along with chest discomfort or troubled breathing while you are using this medicine. This could be symptoms of a serious lung disorder called pulmonary fibrosis. The amount of medicine that you take depends on the strength of the medicine.
The benefit of continued treatment should be regularly reassessed taking into account the risk of fibrotic reactions and valvulopathy (see sections 4.3, 4.4 and 4.8). These might include nausea, vomiting, gastric complaints, hypotension, nasal congestion, confusion hallucinations, psychosis or thought/perception disturbances. Treated with Cabaser for a long period and have or had fibrotic reactions (scar tissue) affecting your heart. Cabaser should not be https://daledigital.net/2025/02/27/steroids-understanding-their-use-effects-and-6/ administered concurrently with –D2 antagonists, such as Phenothiazines, Butyrophenones, Thioxanthenes, Or Metoclopramide. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. If you have any questions about this medicine ask your pharmacist.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals.